ES2113322B1 - Virus mixomatoso recombinante. - Google Patents
Virus mixomatoso recombinante.Info
- Publication number
- ES2113322B1 ES2113322B1 ES09601551A ES9601551A ES2113322B1 ES 2113322 B1 ES2113322 B1 ES 2113322B1 ES 09601551 A ES09601551 A ES 09601551A ES 9601551 A ES9601551 A ES 9601551A ES 2113322 B1 ES2113322 B1 ES 2113322B1
- Authority
- ES
- Spain
- Prior art keywords
- mixomatous
- viruses
- recombinant
- vaccine
- leporids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000700605 Viruses Species 0.000 title abstract 6
- 229960005486 vaccine Drugs 0.000 abstract 3
- 230000002238 attenuated effect Effects 0.000 abstract 2
- 239000000427 antigen Substances 0.000 abstract 1
- 102000036639 antigens Human genes 0.000 abstract 1
- 108091007433 antigens Proteins 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9508128A FR2736358B1 (fr) | 1995-07-05 | 1995-07-05 | Virus myxomateux recombinant |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES2113322A1 ES2113322A1 (es) | 1998-04-16 |
| ES2113322B1 true ES2113322B1 (es) | 1998-12-01 |
Family
ID=9480712
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES09601551A Expired - Fee Related ES2113322B1 (es) | 1995-07-05 | 1996-07-05 | Virus mixomatoso recombinante. |
Country Status (4)
| Country | Link |
|---|---|
| DE (1) | DE19627193B4 (enrdf_load_stackoverflow) |
| ES (1) | ES2113322B1 (enrdf_load_stackoverflow) |
| FR (2) | FR2736358B1 (enrdf_load_stackoverflow) |
| IT (1) | IT1286307B1 (enrdf_load_stackoverflow) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2153284B1 (es) * | 1998-06-10 | 2001-09-01 | Fundacion Para El Estudio Y De | Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos. |
| DK1370668T3 (da) * | 2001-03-08 | 2006-06-06 | Akzo Nobel Nv | Leporipox-baserede vektorvacciner |
| FR2946536B1 (fr) * | 2009-06-11 | 2011-07-29 | Agronomique Inst Nat Rech | Utilisation d'une souche attenuee de myxoma virus comme oncolytique |
| CA2990133A1 (en) | 2015-06-19 | 2017-03-09 | Sillajen, Inc. | Compositions and methods for viral embolization |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5869312A (en) * | 1992-01-13 | 1999-02-09 | Syntro Corporation | Recombinant swinepox virus |
-
1995
- 1995-07-05 FR FR9508128A patent/FR2736358B1/fr not_active Expired - Lifetime
-
1996
- 1996-07-05 DE DE19627193A patent/DE19627193B4/de not_active Expired - Lifetime
- 1996-07-05 IT IT96TO000578A patent/IT1286307B1/it active IP Right Grant
- 1996-07-05 ES ES09601551A patent/ES2113322B1/es not_active Expired - Fee Related
-
2011
- 2011-11-15 FR FR11C0050C patent/FR11C0050I2/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| ITTO960578A1 (it) | 1998-01-05 |
| FR11C0050I1 (enrdf_load_stackoverflow) | 2011-12-16 |
| DE19627193B4 (de) | 2007-08-30 |
| ES2113322A1 (es) | 1998-04-16 |
| DE19627193A1 (de) | 1997-03-20 |
| FR2736358B1 (fr) | 1997-09-26 |
| IT1286307B1 (it) | 1998-07-08 |
| FR2736358A1 (fr) | 1997-01-10 |
| ITTO960578A0 (enrdf_load_stackoverflow) | 1996-07-05 |
| FR11C0050I2 (fr) | 2012-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR020080A1 (es) | UNA VACUNA PARA LA INMUNIZACIoN TERAPÉUTICA O PROFILÁCTICA CONTRA EL VIRUS ENCEFALITIS EQUINA VENEZOLANA,Y, UNA COMPOSICIoN FARMACÉUTICA | |
| ES2664505T3 (es) | Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas | |
| PT1294893E (pt) | Modificacao do antigenio nuclear de hepatite b | |
| ES2061996T3 (es) | Regiones no esenciales de avipoxvirus. | |
| ES2191663T3 (es) | Virus recombinante de la viruela porcina. | |
| BR9912410A (pt) | Vacina para imunização de aves, e, processos para imunizar uma ave e para preparar uma vacina para imunizar uma ave | |
| BR9605153B1 (pt) | vacina de combinação, e, kit de vacinação. | |
| CY1115749T1 (el) | Κυκλοϊος χοιρων, νουκλεϊνικα οξεα, πολυπεπτιδια και εμβολια | |
| CO2021011040A2 (es) | Virus adenoasociado recombinante para el tratamiento de la neurodegeneración de inicio en adultos asociada a grn | |
| ES2124532T3 (es) | Sistema vector-huesped utilizable en terapia genica. | |
| PT920510E (pt) | Quimeras de gnrh-leucotoxina | |
| ES2163394T3 (es) | Regiones serorreactivas situadas en las proteinas e1 y e2 de hpv16. | |
| AR248045A1 (es) | Procedimiento para producir un virus de avipox recombinante, un cultivo de celulas eucariotica, una vacuna y para expresar la totalidad o parte de una proteina heterologa, secuencia de transferencia | |
| ES2138784T3 (es) | Antigenos sinteticos para la deteccion de anticuerpos contra el virus de la hepatitis c. | |
| ES2143507T3 (es) | Vacunas contra la enfermedad de aujeszky y de otras enfermedades animales que contienen mutantes del virus de la pseudorrabia. | |
| AR025503A1 (es) | Composiciones de vacuna para hepatitis y hpv | |
| WO1997011190A3 (en) | Dna construct comprising a muscle specific regulatory element for immunization or gene therapy | |
| ES2123558T3 (es) | Antigenos peptidicos del vhc y procedimiento para la determinacion del vhc. | |
| ES2113322B1 (es) | Virus mixomatoso recombinante. | |
| DK366483A (da) | Gen, dna-transfervektor eller underenhed heraf, der koder for human preprorelaxin eller en underenhed deraf, fremgangsmaade til fremstilling af samme samt fremgangsmaade til fremstilling af human preprorelaxin eller en underenhed deraf | |
| ES2134197T3 (es) | Vacunas contra el virus del herpes simplex vp16. | |
| AR019250A1 (es) | Formas atenuadas del virus de la diarrea viral bovina, molecula de acido nucleico, vector, uso, metodo para modificar el genoma viral de tipo salvaje, genoma modificado, vacuna, metodo para atenuar un virus bvd de tipo salvaje | |
| Lardinois et al. | Stronger interference of avian influenza virus–specific than Newcastle disease virus–specific maternally derived antibodies with a recombinant NDV-H5 vaccine | |
| KR940003566A (ko) | 재조합 아데노바이러스 백신 | |
| CL2025001325A1 (es) | Construcciones de ácido nucleico, vectores virales y partículas virales |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EC2A | Search report published |
Date of ref document: 19980416 Kind code of ref document: A1 Effective date: 19980416 |
|
| FD2A | Announcement of lapse in spain |
Effective date: 20161026 |